Showing results (1001-1010 of 1,194) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|November 1, 2019
The win ratio: Impact of censoring and follow-up time and use with nonproportional hazardsGaohong Dong, Bo Huang, Yu-Wei Chang, et al.Pharmaceutical Statistics|January 11, 2020
What matters most? Different stakeholder perspectives on estimands for an invented case study in COPDOliver N Keene, Stephen Ruberg, Alexander Schacht, et al.Pharmaceutical Statistics|January 21, 2019
Assessment of individual bioequivalence using sufficient bootstrap procedureUfuk BeyaztasPharmaceutical Statistics|January 16, 2019
A comparative study of confidence intervals to assess biosimilarity from analytical dataJorge Quiroz, Richard Montes, Heliang Shi, et al.Pharmaceutical Statistics|February 2, 2019
Hazard ratio inference in stratified clinical trials with time-to-event endpoints and limited sample sizeRengyi Xu, Devan V Mehrotra, Pamela A ShawPharmaceutical Statistics|December 28, 2018
Investigation of the properties of the "switching decision rule" described in the Japanese guideline for human bioequivalence studiesYoichi IiPharmaceutical Statistics|November 28, 2018
Treatment effect quantification for time-to-event endpoints-Estimands, analysis strategies, and beyondKaspar RufibachPharmaceutical Statistics|December 24, 2019
A Bayesian approach to sequential analysis in post-licensure vaccine safety surveillanceRongxia Li, Brock Stewart, Charles RosePharmaceutical Statistics|January 7, 2020
Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designsClaire L Smith, Zachary Thomas, Nathan Enas, et al.Pharmaceutical Statistics|April 7, 2020
Estimation of group means in generalized linear mixed modelsJiexin Duan, Michael Levine, Junxiang Luo, et al.Pageof 120